Table 1.
Parameter | Control | DAAO | Sac/Val | Val | Normal Range (Reference) |
---|---|---|---|---|---|
n | 3 | 6 | 6 | 5 | |
Sodium, mEq/L | 191.8 ± 4.4 | 164.5 ± 4.4 | 177.7 ± 5.9 | 176.0 ± 9.9 | 141–149 (8a) |
Potassium, mEq/L | 4.8 ± 0.5 | 5.2 ± 0.3 | 5.3 ± 0.3 | 5.2 ± 0.3 | 5.2–7.8 (8a) |
Chloride, mEq/L | 144.8 ± 5.5 | 118.0 ± 4.0 | 132.7 ± 5.4 | 131.3 ± 10.6 | 102–109 (8a) |
ALT, U/L | 68.3 ± 11.5 | 60.3 ± 9.6 | 58.3 ± 7.4 | 96.8 ± 25.8 | 20–42 (8a) |
AST, U/L | 97.0 ± 18.2 | 165.2 ± 41.3 | 128.2 ± 30.9 | 223.6 ± 91.5 | 39–84 (8a) |
Creatinine, mg/dL | 0.3 ± 0.0 | 0.2 ± 0.0 | 0.5 ± 0.1** | 0.3 ± 0.0 | 0.3–0.5 (4) |
BUN, mg/dL | 35.0 ± 3.0 | 34.3 ± 2.3 | 49.7 ± 3.7* | 43.4 ± 4.9 | 16–23 (8a) |
Values are means ± SE; n = no. of rats. Serum chemistry values of control (n = 3), d-amino acid oxidase (DAAO)-expressing rats (n = 6), and DAAO-expressing rats then treated with sacubitril/valsartan (Sac/Val; n = 6) or valsartan (Val; n = 5). ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen.
P < 0.05,
P < 0.01 for sacubitril/valsartan vs. DAAO, obtained by 1-way ANOVA with Šídák’s multiple-comparison test or Kruskal-Wallis test followed by Dunn’s multiple-comparison test.